In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...
In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.
"The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results